HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ivar Tjernberg Selected Research

Lyme Neuroborreliosis

7/2022Brain damage markers neuron-specific enolase (NSE) and S100B in serum in children with Lyme neuroborreliosis-detection and evaluation as prognostic biomarkers for clinical outcome.
5/2020Complement activation in individuals with previous subclinical Lyme borreliosis and patients with previous Lyme neuroborreliosis.
1/2020Cytokines and chemokines in cerebrospinal fluid in relation to diagnosis, clinical presentation and recovery in children being evaluated for Lyme neuroborreliosis.
10/2018The chemokine CXCL13 in cerebrospinal fluid in children with Lyme neuroborreliosis.
1/2018Subclinical Lyme borreliosis is common in south-eastern Sweden and may be distinguished from Lyme neuroborreliosis by sex, age and specific immune marker patterns.
11/2016Evaluation of two assays for CXCL13 analysis in cerebrospinal fluid for laboratory diagnosis of Lyme neuroborreliosis.
4/2011Indications of Th1 and Th17 responses in cerebrospinal fluid from patients with Lyme neuroborreliosis: a large retrospective study.
2/2011Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis.
2/2010Mapping of hormones and cortisol responses in patients after Lyme neuroborreliosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ivar Tjernberg Research Topics

Disease

9Lyme Neuroborreliosis
07/2022 - 02/2010
5Leukocytosis (Pleocytosis)
07/2022 - 02/2011
4Lyme Disease (Disease, Lyme)
05/2020 - 01/2017
2Coinfection
01/2021 - 01/2021
2Inflammation (Inflammations)
01/2020 - 04/2011
1Relapsing Fever
01/2021
1Tularemia
01/2021
1Anaplasmosis
01/2021
1Babesiosis (Piroplasmosis)
01/2021
1Bartonella Infections (Bartonellosis)
01/2021
1Tick-Borne Diseases (Tick-Borne Disease)
01/2021
1Infections
01/2021
1Rickettsia Infections
01/2021
1Water Intoxication
02/2018
1Paraproteinemias (Monoclonal Gammopathy)
01/2018
1Tick Bites
01/2017
1red meat allergy
01/2017
1Erythema
08/2009

Drug/Important Bio-Agent (IBA)

6AntibodiesIBA
07/2022 - 02/2011
3Biomarkers (Surrogate Marker)IBA
07/2022 - 01/2018
2CytokinesIBA
01/2020 - 04/2011
2ChemokinesIBA
01/2020 - 04/2011
2Chemokine CXCL13IBA
10/2018 - 02/2011
1Phosphopyruvate Hydratase (Enolase)IBA
07/2022
1Anti-Bacterial Agents (Antibiotics)IBA
01/2021
1tert-butylserineIBA
01/2021
1lepirudin (Refludan)FDA Link
05/2020
1ElectrolytesIBA
02/2018
1CreatinineIBA
01/2018
1Immunoglobulin E (IgE)IBA
01/2017
1EnzymesIBA
11/2016
1ImmunosorbentsIBA
11/2016
1Interleukin-17 (Interleukin 17)IBA
04/2011
1Hydrocortisone (Cortisol)FDA LinkGeneric
02/2010
1Hormones (Hormone)IBA
02/2010
1Proteins (Proteins, Gene)FDA Link
08/2009
1Peptides (Polypeptides)IBA
08/2009

Therapy/Procedure

1Aftercare (After-Treatment)
02/2010